Market Closed -
NSE India S.E.
05:13:50 02/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
988
INR
|
+3.61%
|
|
+2.98%
|
+43.35%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,55,290
|
2,73,595
|
4,51,368
|
3,56,774
|
4,97,549
|
9,94,159
|
-
|
-
|
Enterprise Value (EV)
1 |
4,22,549
|
3,29,923
|
4,74,956
|
3,87,665
|
5,03,450
|
9,80,689
|
9,60,828
|
9,40,295
|
P/E ratio
|
19.2
x
|
23.3
x
|
21.2
x
|
7.95
x
|
25.5
x
|
27.6
x
|
26.5
x
|
25.5
x
|
Yield
|
1.01%
|
1.31%
|
0.79%
|
0.72%
|
1.22%
|
0.58%
|
0.59%
|
0.59%
|
Capitalization / Revenue
|
2.7
x
|
1.92
x
|
2.99
x
|
2.34
x
|
2.89
x
|
5.16
x
|
4.73
x
|
4.41
x
|
EV / Revenue
|
3.21
x
|
2.31
x
|
3.14
x
|
2.54
x
|
2.92
x
|
5.09
x
|
4.57
x
|
4.17
x
|
EV / EBITDA
|
14.2
x
|
12
x
|
14.2
x
|
11.6
x
|
14.1
x
|
19
x
|
17.5
x
|
16.4
x
|
EV / FCF
|
23.2
x
|
20.6
x
|
19.5
x
|
43
x
|
30.4
x
|
34.3
x
|
32.6
x
|
28.1
x
|
FCF Yield
|
4.32%
|
4.85%
|
5.14%
|
2.33%
|
3.29%
|
2.92%
|
3.07%
|
3.56%
|
Price to Book
|
3.42
x
|
2.64
x
|
3.47
x
|
2.1
x
|
2.84
x
|
4.83
x
|
4.22
x
|
3.73
x
|
Nbr of stocks (in thousands)
|
10,23,743
|
10,23,743
|
10,23,743
|
10,23,743
|
10,12,204
|
10,06,234
|
-
|
-
|
Reference price
2 |
347.0
|
267.2
|
440.9
|
348.5
|
491.6
|
988.0
|
988.0
|
988.0
|
Announcement Date
|
29/05/19
|
19/06/20
|
27/05/21
|
20/05/22
|
18/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,31,656
|
1,42,531
|
1,51,022
|
1,52,652
|
1,72,374
|
1,92,760
|
2,10,288
|
2,25,568
|
EBITDA
1 |
29,731
|
27,392
|
33,410
|
33,407
|
35,755
|
51,577
|
54,981
|
57,227
|
EBIT
1 |
23,745
|
20,427
|
26,162
|
26,277
|
31,372
|
44,151
|
46,107
|
47,938
|
Operating Margin
|
18.04%
|
14.33%
|
17.32%
|
17.21%
|
18.2%
|
22.9%
|
21.93%
|
21.25%
|
Earnings before Tax (EBT)
1 |
23,821
|
14,954
|
22,848
|
28,381
|
25,897
|
45,696
|
48,306
|
49,950
|
Net income
1 |
18,488
|
11,766
|
21,336
|
44,873
|
19,603
|
35,800
|
37,344
|
38,554
|
Net margin
|
14.04%
|
8.26%
|
14.13%
|
29.4%
|
11.37%
|
18.57%
|
17.76%
|
17.09%
|
EPS
2 |
18.06
|
11.49
|
20.84
|
43.83
|
19.30
|
35.84
|
37.33
|
38.75
|
Free Cash Flow
1 |
18,249
|
16,013
|
24,390
|
9,015
|
16,579
|
28,616
|
29,501
|
33,466
|
FCF margin
|
13.86%
|
11.23%
|
16.15%
|
5.91%
|
9.62%
|
14.85%
|
14.03%
|
14.84%
|
FCF Conversion (EBITDA)
|
61.38%
|
58.46%
|
73%
|
26.99%
|
46.37%
|
55.48%
|
53.66%
|
58.48%
|
FCF Conversion (Net income)
|
98.71%
|
136.1%
|
114.31%
|
20.09%
|
84.57%
|
79.93%
|
79%
|
86.8%
|
Dividend per Share
2 |
3.500
|
3.500
|
3.500
|
2.500
|
6.000
|
5.765
|
5.817
|
5.816
|
Announcement Date
|
29/05/19
|
19/06/20
|
27/05/21
|
20/05/22
|
18/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
37,956
|
38,467
|
40,254
|
37,848
|
36,550
|
38,638
|
40,727
|
41,347
|
43,623
|
50,106
|
51,396
|
46,971
|
44,460
|
53,450
|
EBITDA
1 |
8,069
|
8,553
|
9,330
|
8,608
|
8,741
|
7,177
|
8,301
|
8,153
|
9,560
|
13,141
|
15,324
|
11,495
|
10,414
|
15,357
|
EBIT
1 |
6,265
|
6,667
|
7,503
|
6,760
|
6,909
|
5,323
|
6,523
|
6,335
|
7,744
|
10,770
|
13,526
|
10,542
|
8,150
|
13,313
|
Operating Margin
|
16.51%
|
17.33%
|
18.64%
|
17.86%
|
18.9%
|
13.78%
|
16.02%
|
15.32%
|
17.75%
|
21.49%
|
26.32%
|
22.44%
|
18.33%
|
24.91%
|
Earnings before Tax (EBT)
1 |
6,272
|
-
|
7,546
|
32,890
|
5,990
|
5,729
|
6,810
|
6,428
|
7,801
|
4,858
|
13,292
|
10,296
|
9,038
|
12,639
|
Net income
1 |
5,272
|
6,790
|
5,872
|
30,023
|
5,004
|
3,974
|
5,183
|
5,225
|
6,229
|
2,966
|
10,869
|
7,846
|
6,895
|
9,689
|
Net margin
|
13.89%
|
17.65%
|
14.59%
|
79.33%
|
13.69%
|
10.29%
|
12.73%
|
12.64%
|
14.28%
|
5.92%
|
21.15%
|
16.7%
|
15.51%
|
18.13%
|
EPS
|
5.150
|
-
|
-
|
-
|
4.890
|
3.880
|
-
|
5.150
|
6.150
|
2.930
|
-
|
8.900
|
7.690
|
8.485
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/02/21
|
27/05/21
|
11/08/21
|
29/10/21
|
03/02/22
|
20/05/22
|
10/08/22
|
11/11/22
|
03/02/23
|
18/05/23
|
11/08/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
67,259
|
56,328
|
23,588
|
30,891
|
5,901
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
13,470
|
33,332
|
53,864
|
Leverage (Debt/EBITDA)
|
2.262
x
|
2.056
x
|
0.706
x
|
0.9247
x
|
0.165
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
18,249
|
16,013
|
24,390
|
9,015
|
16,579
|
28,616
|
29,501
|
33,466
|
ROE (net income / shareholders' equity)
|
19.3%
|
11.3%
|
18.3%
|
14.3%
|
11.4%
|
18%
|
16.2%
|
15%
|
ROA (Net income/ Total Assets)
|
8.9%
|
4.99%
|
8.97%
|
8.32%
|
7.32%
|
13.8%
|
12.2%
|
11.7%
|
Assets
1 |
2,07,730
|
2,35,792
|
2,37,857
|
5,39,514
|
2,67,760
|
2,59,924
|
3,06,524
|
3,30,371
|
Book Value Per Share
2 |
101.0
|
101.0
|
127.0
|
166.0
|
173.0
|
205.0
|
234.0
|
265.0
|
Cash Flow per Share
2 |
28.20
|
24.50
|
32.20
|
20.50
|
26.50
|
43.50
|
39.80
|
44.40
|
Capex
1 |
10,574
|
9,041
|
8,540
|
12,026
|
10,309
|
9,418
|
9,700
|
9,950
|
Capex / Sales
|
8.03%
|
6.34%
|
5.65%
|
7.88%
|
5.98%
|
4.89%
|
4.61%
|
4.41%
|
Announcement Date
|
29/05/19
|
19/06/20
|
27/05/21
|
20/05/22
|
18/05/23
|
-
|
-
|
-
|
Average target price
844.6
INR Spread / Average Target -14.51% Consensus |
1st Jan change
|
Capi.
|
---|
| +43.35% | 11.5B | | +20.61% | 43.18B | | +20.67% | 22.59B | | +14.56% | 14.56B | | +13.94% | 13.54B | | -8.37% | 6.93B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +10.21% | 5.36B | | -2.27% | 4.81B |
Generic Pharmaceuticals
|